Pharmacological platelet inhibition and platelet depletion/reconstitution experiments provide further evidence for the critical role of CCL5-mediated platelet function in promoting cardiac inflammation and remodeling during Ang II-induced hypertension. The gene discussed is CCL5; the disease is Hypertension.